Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Disruption of axonal transport in neurodegeneration
Sarah H. Berth, Thomas E. Lloyd
Sarah H. Berth, Thomas E. Lloyd
Published June 1, 2023
Citation Information: J Clin Invest. 2023;133(11):e168554. https://doi.org/10.1172/JCI168554.
View: Text | PDF
Review Article has an altmetric score of 18

Disruption of axonal transport in neurodegeneration

  • Text
  • PDF
Abstract

Neurons are markedly compartmentalized, which makes them reliant on axonal transport to maintain their health. Axonal transport is important for anterograde delivery of newly synthesized macromolecules and organelles from the cell body to the synapse and for the retrograde delivery of signaling endosomes and autophagosomes for degradation. Dysregulation of axonal transport occurs early in neurodegenerative diseases and plays a key role in axonal degeneration. Here, we provide an overview of mechanisms for regulation of axonal transport; discuss how these mechanisms are disrupted in neurodegenerative diseases including Alzheimer’s disease, Parkinson’s disease, Huntington’s disease, hereditary spastic paraplegia, amyotrophic lateral sclerosis, and Charcot-Marie-Tooth disease; and discuss therapeutic approaches targeting axonal transport.

Authors

Sarah H. Berth, Thomas E. Lloyd

×

Total citations by year

Year: 2025 2024 2023 2009 Total
Citations: 16 20 4 1 41
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (41)

Title and authors Publication Year
Biological Basis of Cell Trafficking: A General Overview
Gimeno\u2010Agud H, Díaz\u2010Osorio Y, Oyarzábal A
Journal of Inherited Metabolic Disease 2025
Targeted demethylation of cathepsin D via epigenome editing rescues pathology in Alzheimer's disease mouse model
Park M, Ryu H, Heo S, Kim B, Park J, Lim KH, Han SB, Park H
Theranostics 2025
KIF21A-associated peripheral neuropathy defined by impaired binding with TUBB3
Borja NA, Zafeer MF, Bivona S, Peart L, Gultekin SH, Bademci G, Tekin M
Journal of medical genetics 2025
Advances in Huntington’s Disease Biomarkers: A 10-Year Bibliometric Analysis and a Comprehensive Review
Aqel S, Ahmad J, Saleh I, Fathima A, Al Thani AA, Mohamed WM, Shaito AA
Biology 2025
RhoA/ROCK/GSK3β Signaling: A Keystone in Understanding Alzheimer’s Disease
Medd MM, Yon JE, Dong H
Current Issues in Molecular Biology 2025
Axonal transport of CHMP2b is regulated by kinesin-binding protein and disrupted by CHMP2bintron5
Kirwan KR, Puerta-Alvarado V, Waites CL
Life Science Alliance 2025
A Novel Histone Deacetylase 6 Inhibitor, 4-FHA, Improves Scopolamine-Induced Cognitive and Memory Impairment in Mice
Seo JY, Kim J, Ko YH, Lee BR, Hur KH, Jung YH, Park HJ, Lee SY, Jang CG
Biomolecules & Therapeutics 2025
Targeting Tau Protein with Proximity Inducing Modulators: A New Frontier to Combat Tauopathies
Uliassi E, Bolognesi ML, Milelli A
ACS Pharmacology & Translational Science 2025
Overview of Metformin and Neurodegeneration: A Comprehensive Review
Kruczkowska W, Gałęziewska J, Buczek P, Płuciennik E, Kciuk M, Śliwińska A
Pharmaceuticals 2025
Clinical phenotypes of Alzheimer’s disease: investigating atrophy patterns and their pathological correlates
Reijner N, Frigerio I, Bouwman MM, Boon BD, Guizard N, Jubault T, Hoozemans JJ, Rozemuller AJ, Bouwman FH, Barkhof F, Gordon E, van de Berg WD, Jonkman LE
Alzheimer's Research & Therapy 2025
A novel antidepressant mechanism of baicalin: enhancing KIF5A-mediated axoplasmic transport and vesicular trafficking in glutamatergic neurons
Lu S, Shen J, Jin X, Zhang C, Wang B, Liu X, Bai M, Xu E, Yan X, Li Y
Frontiers in Pharmacology 2025
The role of glutamate dehydrogenase in the ageing brain
Zhou T, Wang H
Frontiers in Pharmacology 2025
Disruption of axonal transport in Parkinson’s disease: the role of pathological α-Syn and AMPK/p38 MAPK signaling
Yang X, Ma Z, Lian P, Wu Y, Liu K, Zhang Z, Tang Z, Xu Y, Cao X
NPJ Parkinson's Disease 2025
Amyotrophic Lateral Sclerosis: Focus on Cytoplasmic Trafficking and Proteostasis.
Ms S, Banerjee S, D'Mello SR, Dastidar SG
Molecular neurobiology 2025
Recent advancements in the understanding of the alterations in mitochondrial biogenesis in Alzheimer's disease.
Singh S, Singh RK
Molecular biology reports 2025
The role of autophagy in the pathogenesis and treatment of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD)
Beckers J, Van Damme P
Autophagy Reports 2025
Preparation of Viable Human Neurites for Neurobiological and Neurodegeneration Studies
Brüll M, Geese N, Celardo I, Laumann M, Leist M
Cells 2024
Mitochondria in Alzheimer’s Disease Pathogenesis
Reiss AB, Gulkarov S, Jacob B, Srivastava A, Pinkhasov A, Gomolin IH, Stecker MM, Wisniewski T, De Leon J
Life Sciences 2024
Mitochondria Dysfunction and Neuroinflammation in Neurodegeneration: Who Comes First?
Peggion C, Calì T, Brini M
Antioxidants 2024
Nigral transcriptomic profiles in Engrailed-1 hemizygous mouse models of Parkinson’s disease reveal upregulation of oxidative phosphorylation-related genes associated with delayed dopaminergic neurodegeneration
Belfiori LF, Dueñas Rey A, Ralbovszki DM, Jimenez-Ferrer I, Fredlund F, Balikai SS, Ahrén D, Brolin KA, Swanberg M
Frontiers in aging neuroscience 2024
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice.
Feng T, Du H, Yang C, Wang Y, Hu F
Acta Neuropathologica 2024
Swedish Alzheimer's disease variant perturbs activity of retrograde molecular motors and causes widespread derangement of axonal transport pathways.
Feole M, Pozo Devoto VM, Dragišić N, Arnaiz C, Bianchelli J, Texlová K, Kovačovicova K, Novotny JS, Havas D, Falzone TL, Stokin GB
The Journal of biological chemistry 2024
Cofilactin rod formation mediates inflammation-induced neurite degeneration
Uruk G, Mocanu E, Shaw AE, Bamburg JR, Swanson RA
Cell Reports 2024
The necroptosis cell death pathway drives neurodegeneration in Alzheimer’s disease
Balusu S, De Strooper B
Acta Neuropathologica 2024
Post-GWAS functional analyses of CNTNAP5 suggests its role in glaucomatous neurodegeneration
Chakraborty S, Sarma J, Roy SS, Mitra S, Bagchi S, Das S, Saha S, Mahapatra S, Bhattacharjee S, Maulik M, Acharya M
2024
A Cationic Zn-Phthalocyanine Turns Alzheimer’s Amyloid β Aggregates into Non-Toxic Oligomers and Inhibits Neurotoxicity in Culture
Sheikh AM, Tabassum S, Yano S, Abdullah FB, Wang R, Ikeue T, Nagai A
International Journal of Molecular Sciences 2024
Potential Therapeutic Interventions Targeting NAD+ Metabolism for ALS
Lundt S, Ding S
Cells 2024
KIF5A regulates axonal repair and time-dependent axonal transport of SFPQ granules and mitochondria in human motor neurons
Guerra San Juan I, Brunner J, Eggan K, Toonen RF, Verhage M
bioRxiv 2024
Mitochondrial dysfunction gene expression, DNA methylation, and inflammatory cytokines interaction activate Alzheimer's disease: a multi-omics Mendelian randomization study.
Zhang XX, Wei M, Wang HR, Hu YZ, Sun HM, Jia JJ
Journal of translational medicine 2024
Age-specific and compartment-dependent changes in mitochondrial homeostasis and cytoplasmic viscosity in mouse peripheral neurons.
Sleigh JN, Mattedi F, Richter S, Annuario E, Ng K, Steinmark IE, Ivanova I, Darabán IL, Joshi PP, Rhymes ER, Awale S, Yahioglu G, Mitchell JC, Suhling K, Schiavo G, Vagnoni A
Aging cell 2024
Therapeutic approaches targeting aging and cellular senescence in Huntington's disease
Bhat AA, Moglad E, Afzal M, Thapa R, Almalki WH, Kazmi I, Alzarea SI, Ali H, Pant K, Singh TG, Dureja H, Singh SK, Dua K, Gupta G, Subramaniyan V
CNS Neuroscience & Therapeutics 2024
Proteome Dynamics in iPSC-Derived Human Dopaminergic Neurons
Cavarischia-Rega C, Sharma K, Fitzgerald JC, Macek B
Molecular & Cellular Proteomics : MCP 2024
Tubulin acetyltransferases access and modify the microtubule luminal K40 residue through anchors in taxane-binding pockets.
Luo J, Lam WH, Yu D, Chao VC, Zopfi MN, Khoo CJ, Zhao C, Yan S, Liu Z, Li XD, Zheng C, Zhai Y, Ti SC
Nature structural & molecular biology 2024
Unraveling the interplay of kinesin-1, tau, and microtubules in neurodegeneration associated with Alzheimer's disease.
Durairajan SSK, Selvarasu K, Singh AK, Patnaik S, Iyaswamy A, Jaiswal Y, Williams LL, Huang JD
Frontiers in cellular neuroscience 2024
Interaction Between Aging-Related Elastin-Derived Peptide (VGVAPG) and Sirtuin 2 and its Impact on Functions of Human Neuron Cells in an In Vitro Model.
Skóra B, Piechowiak T, Szychowski KA
Molecular neurobiology 2024
The node of Ranvier influences the in vivo axonal transport of mitochondria and signaling endosomes
Tosolini AP, Abatecola F, Negro S, Sleigh JN, Schiavo G
iScience 2024
Cytoskeletal adaptation following long-term dysregulation of actomyosin in neuronal processes
Cisterna BA, Skruber K, Jane ML, Camesi CI, Nguyen ID, Warp PV, Black JB, Butler MT, Bear JE, Tracy-Ann R, Vitriol EA
2023
Alzheimer’s disease: an axonal injury disease?
Dan L, Zhang Z
Frontiers in aging neuroscience 2023
Interactions of amyloidogenic proteins with mitochondrial protein import machinery in aging-related neurodegenerative diseases
Reed AL, Mitchell W, Alexandrescu AT, Alder NN
Frontiers in physiology 2023
Loss of TMEM106B exacerbates Tau pathology and neurodegeneration in PS19 mice.
Feng T, Du H, Hu F
bioRxiv : the preprint server for biology 2023
Pulmonary surfactant: an immunological perspective
ZC Chroneos, Z Sever-Chroneos, VL Shepherd
Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2009

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 1 news outlets
Posted by 11 X users
On 1 Facebook pages
Referenced in 1 Wikipedia pages
126 readers on Mendeley
See more details